|
SPG
|
Real Estate |
Goldman Sachs |
Downgrade
|
Buy
→
Neutral
|
—
|
$65.5B
|
$169.40
|
-0.3%
|
-0.8%
|
+0.1%
|
+0.5%
|
-2.1%
|
+1.3%
|
|
TROW
|
Financial Services |
Morgan Stanley |
Downgrade
|
Equal Weight
→
Underweight
|
—
|
$22.8B
|
$71.94
|
-0.9%
|
-3.6%
|
-0.1%
|
-1.0%
|
+0.3%
|
-0.9%
|
|
BEN
|
Financial Services |
Morgan Stanley |
Downgrade
|
Equal Weight
→
Underweight
|
—
|
$16.1B
|
$43.91
|
-1.1%
|
-3.8%
|
-0.4%
|
-1.6%
|
+0.0%
|
+0.2%
|
|
MAC
|
Real Estate |
Goldman Sachs |
Downgrade
|
Neutral
→
Sell
|
—
|
$5.6B
|
$64.62
|
-0.3%
|
-0.7%
|
+0.0%
|
+0.2%
|
-2.3%
|
+1.0%
|
|
AXTI
|
Technology |
B. Riley Securities |
Downgrade
|
Buy
→
Neutral
|
—
|
$4.6B
|
$6.60
|
-4.5%
|
-15.9%
|
+3.6%
|
-3.5%
|
-8.1%
|
+11.8%
|
|
AXTI
|
Technology |
B. Riley FBR |
Downgrade
|
Buy
→
Neutral
|
—
|
$4.6B
|
$6.60
|
-4.5%
|
-15.9%
|
+3.6%
|
-3.5%
|
-8.1%
|
+11.8%
|
|
PRKS
|
Consumer Cyclical |
Citigroup |
Downgrade
|
Neutral
→
Sell
|
—
|
$1.9B
|
$18.88
|
-2.9%
|
-4.0%
|
-2.3%
|
-0.8%
|
-1.9%
|
+0.5%
|
|
USPH
|
Healthcare |
Barrington Research |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$935M
|
$69.90
|
-0.7%
|
-2.5%
|
-0.4%
|
-4.6%
|
-0.9%
|
-1.8%
|